Clinical Trials
56 trialsA Study to Test How Well Different Doses of BI 1831169 in Combination With an Anti-PD1 Antibody Are Tolerated in Japanese People With Different Advanced Cancers
Boehringer Ingelheim
A Study of SI-B036 in Patients With Locally Advanced or Metastatic Solid Tumors
Sichuan Baili Pharmaceutical Co., Ltd.
A First-in-human Phase I Study to Evaluate EMB-15 in Patients With Locally Advanced or Metastatic Solid Tumors.
Shanghai EpimAb Biotherapeutics Co., Ltd.
A Pilot Unrestricted Payment Program for Early-stage Cancer Patients: the PAYMENT Trial
Fred Hutchinson Cancer Center
Study of GS-2426 in Participants With Advanced Solid Tumors
Gilead Sciences
Safety and Activity of HF50 in Patients With Advanced Solid Tumors
HighField Biopharmaceuticals Corporation
A Study of Risvutatug Rezetecan in Combination With Ivonescimab in Participants With Advanced Solid Tumors (EMBOLD PanTumour-103)
GlaxoSmithKline
SELECTmeso
University of Southampton
FAK Inhibitor in Patients With Advanced Solid Tumors
InxMed (Shanghai) Co., Ltd.
PRODIGE 104 B
Institut Paoli-Calmettes
A Single-Arm, Open-Label Phase Ia/Ib Clinical Trial Evaluating the Safety, Tolerability, Pharmacokinetic Profile, and Preliminary Efficacy of FS-207 in Patients With Advanced Solid Tumors With High Microsatellite Instability (MSI-H)
Foresight Therapeutics (Hefei) Co., Ltd.
Phase I/II Study of SCTB41 Plus SCTB39-1with or Without Standard Therapy in Advanced Solid Tumours
Sinocelltech Ltd.
A Study of BL-ARC002 in Patients With Locally Advanced or Metastatic Solid Tumors
Sichuan Baili Pharmaceutical Co., Ltd.
A Study of SYS6051 in Subjects With Advanced Solid Tumors
CSPC Megalith Biopharmaceutical Co.,Ltd.
SKB118 Injection in Advanced Solid Tumors
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
mRNA-LNP
IntraAb, Inc.
JH021 in Patients With Advanced Solid Tumors or EGFR-Mutant NSCLC
Biotech Pharmaceutical Co., Ltd.
An Exploratory Study of Personalized Cancer Vaccine in Adjuvant Therapy of Solid Tumors
Suzhou Abogen Biosciences Co., Ltd.
SKB565 for Injection in Advanced Solid Tumors
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
A Spiritual Health Intervention (PATH) for Improving Spiritual, Religious and Emotional Distress in Cancer Patients
Fred Hutchinson Cancer Center
A Phase I Clinical Study of AK150 in Advanced Malignant Solid Tumor
Akeso
UCSF Biobank for Hereditary Cancers and Tumor-Associated Mutations
University of California, San Francisco
ENCOMPASS STUD
IR INNOVATE RESEARCH PRIVATE LIMITED
WTX-212C-IIT
Zhejiang Provincial People's Hospital
This Study Aims to Evaluate the Efficacy and Safety of QLS1317 in Patients With MSI-H/dMMR Advanced Solid Tumors.
Shanghai Qilu Pharmaceutical Research and Development Center LTD
COMETH
University of Kansas Medical Center
ATOM-1st
Chirec
A Phase I Clinical Study of HLX316 in Participants With Advanced/Metastatic Solid Tumors
Shanghai Henlius Biotech
NIVALIS
West China Hospital
A I/II Phase Clinical Study to Evaluate the Safety and Efficacy of RC288 in the Treatment of Solid Tumors
RemeGen Co., Ltd.
Testing an Educational Program to Improve Goals of Care Conversations Between Patients and Their Care Teams
SWOG Cancer Research Network
A Phase I Clinical Study of HLX3902 in Patients With mCRPC and Other Advanced Tumours
Shanghai Henlius Biotech
A Single-Arm Clinical Study of Autologous Tumor-Infiltrating Lymphocyte Injection (GT307) in the Treatment of Metastatic and Recurrent Advanced Solid Tumors
Grit Biotechnology
Retinoblastoma Consolidation in Egyptians
Assiut University
Safety, Pharmacokinetics (PK), and Efficacy of ONC-783 in Advanced Solid Tumors
OncoC4, Inc.
Quality of End-of-Life Care for Children With Cancer
Children's Oncology Group
A Phase Ib/II Study Evaluating Injectable ALK-N001 in Patients With Advanced Solid Tumors
Zhejiang Anglikang Pharmaceutical Co., Ltd.
First-In-Human Study of KHN922 for Injection
Chengdu Kanghong Biotech Co., Ltd.
A Phase 1 Study of OTS-412 (Recombinant Oncolytic Vaccinia Virus) in Treatment-refractory Solid Tumor Patients
Bionoxx Inc.
Iparomlimab Plus Tovorilimab Combined With Bevacizumab and Chemotherapy as First-Line Treatment for Advanced Mesothelioma
Fudan University
Clinical Studies of TQB2930 Injection for the Treatment of Advanced Solid Tumors
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
IPG7236 Combined With Toripalimab in Participants With Advanced Solid Tumors
Nanjing Immunophage Biotech Co., Ltd
ETCABIO
University Hospital, Angers
One Trial of JCXH-211 Intratumoral Injection Combined With Anti-PD-1 Antibody in Patients With Malignant Solid Tumors
Immorna Biotherapeutics, Inc.
Psilocybin With Psychotherapy for Improving Chronic Pain in Cancer Patients Requiring Opioids
Roswell Park Cancer Institute
A Clinical Study GK01 Injection in Subjects With Advanced Malignant Solid Tumors
Beijing Geekgene Technology Co., LTD
Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HLX97 (a KAT6A/B Inhibitor) in Patients With Advanced/Metastatic Solid Tumor
Shanghai Henlius Biotech
A Phase I Clinical Study to Evaluate the Safety, Tolerability, and PK of HLX48 in Advanced/Metastatic Solid Tumors
Shanghai Henlius Biotech
JSKN016HC in Patients With Advanced or Metastatic Solid Malignant Tumors
Jiangsu Alphamab Biopharmaceuticals Co., Ltd
PREDICTO
Assistance Publique Hopitaux De Marseille